The rapid onset and persistence of homologous and heterologous protection " induced by attenuated Venezuelan equine encephalomyelitis (VEE) vaccine -(TC-83) were studied in the hamster, by using challenge response as the index fr.- :Dnaarepresented toindicate that the early protection phenomenon is one it interference, since little or no replication of a challenge virus occurred when it was administered during the vaccine viremia stage.
In a previous publication (5) we reported Finally, the possible mechanism(s) of early that, in the hamster, attenuated Venezuelan protection was investigated. equine encephalomyelitis (VEE) vaccine (TC-83) produced excellent homologous protection MATERIALS AND METHODS as well as 59 and 37% protection against Eastern and Western equine encephalomyelitis Challenge viruses. California strain WEE virus E(3), Cambridge strain EEE virus (3), and Trinidad (EEE, WEE) virus challenge, respectively. strain VEE virus (12) were employed as challenge However, in those studies all challenges were viruses. These strains were lethal to high titers, i.e., made 21 to 30 days postvaccination. Because 107 to 10s0 median lethal doses (LD, 8 in the hamsters were inoculated with 0.5 ml of log,. diluheren tions of virus in cold phosphate-buffered saline, pH " summer of 1971, the studies described h 7.2, containing 1% normal rabbit serum (PBS). For were conducted to determine if the TC-83 vac-viremia determinations with attenuated VEE (TC-3 cine was capable of inducing rapid protection. 83) vaccine, blood specimens were diluted in cold The significance of this is apparent when one PBS. Groups of six 1-to 3-day.old mice (f.D-1 I considers: (i) the speed with which VEE strain; Charles River Mouse Farm, Wilmington, spreads in an equine population, and (ii) the Mass.) were then inoculated intracerebrally (ic) with fact that immunization is often performed in 0.03 ml of log,, dilutions. Titrations end points in areas where active cases are occurring. Also, it hamsters and suckling mice were determined by the was deemed desirable to determine whether method of Reed and Muench (13) and are expressed the vaccine would provide significant. rapid as LD.. per milliliter.
""th v
Vaccination and challenge. The attenuated VEE cross-Iprotection against EEE and WEE, the (TC-83) vaccine has been described (2, 10) . In all two other equine encephalomyelitides endemic experiments, hamsters were inoculated ip with 103 ir, those areas of the United States in which median immunizing doses (ID,.) of the vaccine. VEE outbreaks could be expected to occur. Challenges were made via the ip route at the indi-
cated times using 10' hamster LD, 0 of a given-chal- Ten different animals bled each day; titers exvaccine viremia and HI antibody determina-pressed as log,. suckling mouiseic LDJml. tions, while other randomly selected hamsters 5 Expressed as reciprocal-oftiter; pooled sera from were challenged. with virulent VEE, EEE, or two hamstbes tested on each day postvaccination. WEE viruses. Vaccine viremia appeared as For abbreviations, see footnote to- Table 1 . early as day I postvaccination and persisted others antibody did not appear until day 8. A through day 5 in the majority of hamsters; high degree of homologous and heterologous. however, viremia was demonstrated in some protection was afforded -those animals chalanimals as late as day 7. Termination of the lenged viremi stag geneally oincied wih -t e day during the vaccine viremia stage, viz.
viremic stage generally coincided with, the days 1 through 6, after which heterologous proappearance of HI antibody-to TC-83 virus. HI tection gradually decreased. Only 0 to 2% of antibody to TC-83 virus was detected in indi-nonvaccinated, control animals survived chalvidual animals as early as day 5, whereas in lenge.
"l'TA .. 1 -(<10-40) (160-1280) On day 17 postvaccination, representative 9 ata-,compile from results of several ex-perinumbers of hamsters that survived challenge ments. For abbreviations, see footnote to Table-. with virulent VEE, EEE, or WEE viruses as b Received TC-83 vaccine on day 0, and challenge well as hamsters that-had received.only TC-83 virus indicated on day 1,2, 3,;or 4.postvaccination.-Svaccine on day 0 were exsanguinated, and HI cReciprocai-of geometric mein and-range deterantibody titers were deternmined. The re-mined using pooled sera of two ha mners each; minmaining animals in, each survival group were imum of five pools tested against appropriate anrec dwith the same virus that had tigen (VEE, EEE, or WEE). rechallenged
Received TC-83 vaccine on day 0; but were not been administered on days 1, 2, 3, or 4. As challenged until day 17. controls, hamsters that had received only TC--83 vaccine on day 0 and normal-,hamnsters of the same age were also challenged. On day 34, these animals to withstand rechallenge, one randomly selected surviving animals from all can assume that little or no replication ocgroups were bled for HI antibody determina-curred. This apparent lack bf replication by tions. Results of these studies are summarized the original challenge virus is verified by the in Table 4 . As indicated, there was virtually no HI titers of animals at the time of rechallefige difference in day 17 survival rates between on day 17. Comparable titers were seen in the those animals that had received a previous challenged (primary) and control groups for homologous challenge and those that received each of the three viruses studied. These data only TC-83 vaccine on day 0. Since significant are suggestive of an interference phenomenon replication of the original (day 1 to 4) chal-mediated directly or indirectly by the TC-83 lenge virus should have increased the ability of vaccine. Supporting this belief is the indirect evidence of the ability of EEE and WEE vi- tered TC-83 vaccine (Table 3) , it was of prac- Table 1 .
tical significance to determine whether vacci-
Survivors (no./tota!) by hr of or 24 hr after challenge as well as simultaneVirulent challenge preimmunization:A ously with the challenge viruses. As shown in viruso 0 (simul-" I TC-83 vaccine in man (1, 7, 11; P. J. Bartelloni, personal communication) and animals (5, previously protected by inoculation with TC-6, 14) , no information has been available re-83 vaccine. Here, death or marked increases in garding the ability of the vaccine to induce HI antibody titers to EEE and WEE viruses rapid-homologous and heterologous protection.
were similar in both test and vaccine control In the present study we have demonstrated animals. It should be noted that the failure of thait :protection in the hamster starts as early late challenge with virulent VEE -virus to inas 8 hr postvaccination, and that early-proteccrease the homologous antibody titer is in tion closely parallels the viremia resulting agreement with the results-of our earlier study from infectioin with the vaccine virus. Homolo.
(5). Our findings, in general, are in agreement ' gous and heterologous protection was greatest with those of Hearn and Rainey (9), who during the period of maximum vaccine vire-showed that a variety of laboratory animals mia, i.e, days I to 6. The persistence of heter-were protected against homologous and heterologous protection after this period was not ologous challenge as early as 24 hr postvaccinunexpected in view of the results of an earlier ation with another attenuated strain of VEE study in which we demonstrated the ability of virus, In our study, no attempt was made to -A TC-83 vaccine to elicit 59 and 37% protection determine whether the observed interference -against EEE and WEE virus challenges, re-was interferon-mediated. spectively, 21 to 30 days postvaccination (5).
In terms of field use of the attenuated VEE Our data on early protection strongly.sug-vaccine in equines, the results of these early gest that an interference phenomenon is re-protection studies are of major importance. sponsible for the degree of protection observed. For example, Spertzel and McKinney reported In this case the presence of a replicating, or at that during the 1969 Central American epileast, circulating virus (i.e., TC-83 vaccine) zootic of VEE, all equine cases of VEE prevents superinfection of a host animal with stopped 7 to 10 days after vaccination, even in other viruses. The failure of the challenge vi-areas experiencing active cases of VEE in nonruses to replicate to any appreciable extent immunized animals (R. 0. Spertzel ways: (i) hamsters which survived such a chal.-the majority of thos equines which died or lenge did not show increased resistance to a exhibited clinical illness during the 7-to 10-rechallenge administered after the vaccine vi-day period were infected prior to or shortly remia stage, and (ii) the HI antibody responses after vaccination, then one can also assume of hamsters that were vaccinated and chal-that protection occurs in equines earlier than 7 i4 lenged were similar to those of hamsters that days postvaccination. These assumptions are were only vaccinated. Evidence of the nonspe-supported by Walton's analysis of the VEE cific nature of the early protection is provided outbreaks in Nicaragua and Costa Rica, which by results of experiments in which it was indicates that the vaccine will protect equines shown that EEE and WEE viruses do. indeed, within 3 days even in the presence of concurreplicate in the absence of interfering virus, rent equine VEE infections in a given area (T. namely in the same animals that had been E. Walton, in press).
